These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8540136)

  • 1. [Desmopressin in the treatment of hemorrhagic diathesis].
    Haar D; Hasselbalch HC
    Ugeskr Laeger; 1995 Nov; 157(48):6713-5. PubMed ID: 8540136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with prolonged bleeding time of undefined etiology, and their response to desmopressin.
    Kim HC; Salva K; Fallot PL; Karp GI; Eisele J; Matts L; Heller I; Saidi P
    Thromb Haemost; 1988 Apr; 59(2):221-4. PubMed ID: 3388295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin (DDAVP) in bleeding disorders of childhood.
    Sutor AH
    Semin Thromb Hemost; 1998; 24(6):555-66. PubMed ID: 10066151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Deamino-8-d-arginine vasopressin (DDAVP): a potential new treatment for the bleeding diathesis of acute renal failure.
    Watson AJ; Keogh JA
    Pharmatherapeutica; 1984; 3(9):618-22. PubMed ID: 6728864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia.
    Casonato A; Sartori MT; de Marco L; Girolami A
    Thromb Haemost; 1990 Aug; 64(1):117-20. PubMed ID: 2274916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis.
    Cattaneo M; Tenconi PM; Alberca I; Garcia VV; Mannucci PM
    Thromb Haemost; 1990 Nov; 64(3):358-60. PubMed ID: 2096487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic and hemodynamic effects of vasopressin analogue DDAVP in patients with cirrhosis.
    López P; Otaso JC; Alvarez D; Rojter S; Podestá A; Albornoz L; Terg R; Romero G; Mastai R
    Acta Gastroenterol Latinoam; 1997; 27(2):59-62. PubMed ID: 9339235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin in inherited disorders of platelet function.
    Coppola A; Di Minno G
    Haemophilia; 2008 Jan; 14 Suppl 1():31-9. PubMed ID: 18173692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease.
    McKeown LP; Connaghan G; Wilson O; Hansmann K; Merryman P; Gralnick HR
    Am J Hematol; 1996 Feb; 51(2):158-63. PubMed ID: 8579058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin--a haemostatic drug: state-of-the-art review.
    Lethagen S
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():1-9. PubMed ID: 9088828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
    Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease].
    Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S
    Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDAVP and life-threatening diffuse gastric bleeding in uraemia. Case report.
    Juhl A; Jørgensen F
    Acta Chir Scand; 1987 Jan; 153(1):75-7. PubMed ID: 3495087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of desmopressin in open-heart surgery.
    Cattaneo M
    Haemophilia; 2008 Jan; 14 Suppl 1():40-7. PubMed ID: 18173693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
    Federici AB
    Haemophilia; 2008 Jan; 14 Suppl 1():5-14. PubMed ID: 18173689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin for diabetes insipidus, hemostatic disorders and enuresis.
    Shulman LH; Miller JL; Rose LI
    Am Fam Physician; 1990 Oct; 42(4):1051-7. PubMed ID: 2220513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.